APC and intestinal neoplasm: Mice heterozygous for an adenomatous polyposis coli (APC) mutation and a LRH-1 inactivating mutation developed fewer intestinal tumours than mice harbouring the APC mutation only, and LRH-1 heterozygous mice developed fewer azoxymethane-induced aberrant crypt foci (35).